Rapid Point of Care Diagnostics to Determine Cytomegalovirus Infection Serostatus
$1,500,000N44FY2019AINIH
Zymeron Corporation, Durham NC
Investigators
Abstract
This proposal aims to develop a point-of-care test to measure the antibodies from human blood and to determine the serostatus of cytomegalovirus (CMV) infection.
View original record on NIH RePORTER →